251. Instrumental and transcriptome analysis reveals the chemotherapeutic effects of doxorubicin-loaded black phosphate nanosheets on abiraterone-resistant prostate cancer.
- Author
-
Xu, Haoyang, Liu, Jiaqi, Li, Xiangkai, Li, Jiawei, Lin, Xiao, Li, Zhuowei, Dou, Tong, Gao, Li, Li, Rong, and Lai, Keng Po
- Subjects
- *
DOXORUBICIN , *PROSTATE cancer , *ANDROGEN receptors , *CANCER cell proliferation , *ANDROGEN deprivation therapy , *ABIRATERONE acetate , *PROSTATE - Abstract
• Abiraterone-resistant PC-3 cells alter prostate gland morphogenesis, drug response, immune response, and angiogenesis. • BPNS reduce proliferation and migration of the abiraterone-resistant prostate cancer cells. • BPNS mediate the genes related to cancer cell proliferation, metastasis, and oncogenic signaling pathways. • BPNS control MMP, ATF, and Notch families in abiraterone-resistant PC-3 cells. [Display omitted] Prostate cancer is the second most common cause of cancer-related deaths in men and is common in most developed countries. Androgen deprivation therapy (ADT) that uses abiraterone acetate (AA) is an effective second-line treatment for prostate cancer. However, approximately 20–40% of patients develop primary resistance to abiraterone post-treatment. In this study, we aimed to understand the molecular mechanisms underlying the development of abiraterone resistance in prostate cancer cells and the potential use of black phosphorus nanosheets (BPNS) for treating abiraterone-resistant prostate cancer. We first established abiraterone-resistant prostate cancer PC-3 cells and found that these cells have higher migration ability than normal prostate cancer cells. Using comparative transcriptomic and bioinformatics analyses between abiraterone-sensitive PC-3 and abiraterone-resistant PC-3 cells, we highlighted the differentially expressed genes (DEGs) involved in the biological processes related to prostate gland morphogenesis, drug response, immune response, angiogenesis. We further studied the therapeutic effects of BPNS. Our results show that BPNS reduced the proliferation and migration of abiraterone-resistant PC-3 cells. Bioinformatics analysis, including gene ontology, Kyoto encyclopedia of genes and genomes enrichment analysis, and ingenuity pathway analysis (IPA) of the DEGs, suggested that BPNS treatment controlled cancer cell proliferation, metastasis, and oncogenic signaling pathways. Furthermore, the IPA gene network highlighted the involvement of the MMP family, ATF, and notch families in the anti-prostate cancer function of BPNS. Our findings suggest that BPNS may have a chemotherapeutic function in treating abiraterone-resistant prostate cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF